Allergan's global net sales rose by 9.1 percent to $432.2 million in the 1st quarter ended March 29, and they increased by 12.7 percent in local currencies, but the net income for the period was down to $43.8 million from $52.1 million. Sales of contact lens care products decreased by 11.7 percent to $56.6 million. In local currencies, they were down 6.2 percent, with sales of Complete multi-purpose solutions off 11.5 percent because of less emphasis on the low-margin private label business in this product range.